An interventional study of pudendal block in Reduction in Pain Within 24 Hours of Surgery, sponsored by Raincy Montfermeil Hospital Group. Status unknown at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-14.
Sponsored by Raincy Montfermeil Hospital Group · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 135 studies in Chronic Pain with a site in France — 35 open to participants now, 39 under way, 2 of them phase 3. Chronic Pain · France.
Among the 135 studies in Chronic Pain with a site in France, this one is the 34th largest by planned enrollment of the 67 interventional ones that give a count, is one of 14 that started in 2021, is one of 44 with no phase, and was the 83rd registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →35 of the 135 studies in Chronic Pain with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Ages 18+
Institut Rafael · Sites in France
Ages 18+
Hospital Ambroise Paré Paris · Sites in France
Ages 18–80
Centre Medical ISM (Integrative Systemic Medicine) · Sites in France
Ages 18+
Medtronic · Sites in France, United States, Belgium and 1 more country
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
135 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 13 · Phase 4 3
First in 2003; this study’s year is marked. 14 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 78 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 78 across the 67 interventional studies, 160 across the 68 observational. Of the 84 that completed or were terminated, 11 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
21 of 135 have an industry lead sponsor. The 10 most frequent:
Raincy Montfermeil Hospital Group is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Raincy Montfermeil Hospital Group has 1 study filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
14 of the studies in Chronic Pain with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06964243Institut pour la Pratique et l'Innovation en PSYchologie appliquée (Institut Pi-Psy)Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain | 2026-12-19 |
| NCT07877376Nadine ATTALImpact of Cognitive Impairment on Chronic Pain in Breast Cancer | 2027-01 |
| NCT06811077Fondation Hôpital Saint-JosephEvaluation of Individual Health Coaching Sessions Provided by a Patient Expert As Part of Therapeutic Education for Patients Registered At the Chronic Pain Consultation | 2027-01-15 |
| NCT07280338University Hospital, BrestEmotional Intelligence and Chronic Orofacial Pain | 2027-02-09 |
| NCT06841276NovesiaImpact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial | 2027-03 |
Add all 14 to your calendar (.ics) → With an account.
Among the 135 studies in Chronic Pain with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Reconstructive surgery of the clitoris is part of the care offered during a process of care of women victims of MSF. It consists in reconstituting a clitoral neogland after removal of the vulvar excisional scar and recovery of the remaining clitoris. Studies that have monitoring the implementation of this surgery show that it improves the well-being of the patients, brings benefits anatomically, sexual health, personal development, and in the long term decreases chronic pain.
Currently the standard method used in the usual care of the patient is: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco The pudendal block that the investigators want to evaluate in this research, is a technique that has made proven in several types of surgery, associated with very few complications and easily reproducible.
Reconstructive surgery of the clitoris is part of the care offered during a process of care of women victims of MSF. It consists in reconstituting a clitoral neogland after removal of the vulvar excisional scar and recovery of the remaining clitoris. Studies that have monitoring the implementation of this surgery show that it improves the well-being of the patients, brings benefits anatomically, sexual health, personal development, and in the long term decreases chronic pain. Currently the standard method used in the usual care of the patient is: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco The pudendal block that the investigators want to evaluate in this research, is a technique that has made proven in several types of surgery, associated with very few complications and easily reproducible. The human clitoris is the most sensitive organ in the human body, with over 8000 endings nervous. All these endings come from the pudendal nerve, itself most often of nerve roots S3. The main hypothesis is that a bilateral anesthetic block of this nerve would reduce postoperative pain in clitoral surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ultrasound-guided bilateral pudendal block at the start of surgery, in gynecological position: injection of 15 mL of 0.475% Naropein in each ischiorectal fossa.
Procedure: pudendal block
Operated and anesthetized patients according to the standard method within the department
Procedure: pudendal block
general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco
Also known as: standard method
decrease in the mean of the self-reported pain scores in the first 24 hours
decrease in the mean of the self-reported pain scores in the first 24 hours using a Numerical visual scale
Time frame: 24 hours
decrease in pain on the EVN at 2 hours, 6 hours , Day 1 and Day 7 postoperative
decrease in pain on the EVN at 2 hours, 6 hours , Day 1 and Day 7 with the pudental block method
Time frame: 2 hours, 6 hours, Day 1 and Day 7 postoperative
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2021 (actual). Primary completion is estimated for Jan 2023, 15 months after the start.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 15 months is below that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Raincy Montfermeil Hospital Group